August 11, 2026 11:03 am (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
Jharkhand student protest turns tense: Water cannons, lathicharge after Assembly march barricades breached | ‘Mother tongue is as pure as one's mother’: Vijay-led Tamil Nadu government makes Tamil Thaai Vazhthu mandatory in big language push | Indian envoy Kwatra cites US, UK laws to counter ‘myths’ around FCRA Bill | Jharkhand students march to assembly today: JPSC row escalates despite govt action | ‘A morning I will cherish’: Raghav Chadha meets PM Modi, shares photos from ‘enriching’ meeting | Delhi Mercedes crash kills 70-year-old woman: Cop’s son behind wheel, beer bottle found | Indian-origin woman accused of ‘visa fraud’ on X: US Attorney steps in with major clarification | US Senate passes Russia sanctions bill: India can face Trump’s 100% tariff threat | Expired meat, rotten vegetables found at Bengaluru's luxury hotels, legal action begins | 'I'm ready to be humiliated': Vijay, Udhayanidhi Stalin clash in Tamil Nadu Assembly over Cauvery dispute
COVI19 Antibodies
WIKIMEDIA COMMONS

Less than 10 percent of world’s population have developed coronavirus antibodies: WHO Chief Scientist

| @indiablooms | Mar 01, 2021, at 03:42 pm

Geneva/UNI: The World Health Organization (WHO) estimates that less than 10 percent of the global population have antibodies to the coronavirus, WHO Chief Scientist Soumya Swaminathan said.

"Less than 10 per cent of the world’s population actually has antibodies to this virus," Swaminathan said in a Sunday interview, released on the official WHO twitter page.

"Of course in some settings, like particularly in the very high density urban settlements, there are pockets where 50, 60 percent of the population has been exposed to the virus and has antibodies," she said.

The only way to achieve mass herd immunity is through vaccination, the WHO chief scientist stressed.

According to Swaminathan, the currently approved vaccines offer good protection against severe disease, hospitalisation and death from COVID-19. The vaccines’ effectiveness with regard to mild disease and asymptomatic coronavirus infection is still being studied.

More than 114 million coronavirus cases have been confirmed globally since the start of the pandemic last spring. According to Johns Hopkins University data, the global COVID-19 death toll stands at over 2.5 million.

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.